Roche - WA43811 - TOCILIZUMAB IN PEDIATRIC PATIENT

I'm Interested!

A PHASE Ib, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF TOCILIZUMAB IN PEDIATRIC PATIENTS HOSPITALIZED WITH COVID-19

Sex at Birth: Any
Age: Child (Birth - 17)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: COVID-19

Study Purpose

The purpose of this study is to test TCZ in hospitalized pediatric participants with COVID-19 to find out if it is safe, to study the effects, good or bad, and to understand the way your body processes the study drug.

Principal Investigator
Grace McComsey MD

Department/Division
Infectious Disease (Pediatrics)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: SITE00001629
StudyID: 2021-0817
ClinicalTrials.gov: NCT05164133

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422